These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25051937)

  • 41. [Aspirin and risk of perioperative hemorrhage].
    Haas S
    Chirurg; 2006 May; 77(5):453-8. PubMed ID: 16541272
    [No Abstract]   [Full Text] [Related]  

  • 42. Aspirin in the prevention of cardiovascular disease in women.
    Schwartz DJ
    N Engl J Med; 2005 Jun; 352(26):2751-2; author reply 2751-2. PubMed ID: 15987927
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical studies of the effectiveness of aspirin in the prevention of major cardio-cerebrovascular occurrences].
    Mariani M; Biadi O
    Cardiologia; 1995 Dec; 40(12 Suppl 1):423-8. PubMed ID: 8998750
    [No Abstract]   [Full Text] [Related]  

  • 44. Aspirin augmentation of the efficacy of thrombolysis.
    O'Donnell CJ; Jonas MA; Hennekens CH
    Coron Artery Dis; 1995 Dec; 6(12):936-9. PubMed ID: 8723015
    [No Abstract]   [Full Text] [Related]  

  • 45. Warfarin, aspirin, or both after myocardial infarction.
    Pullicino P; Thompson JL
    N Engl J Med; 2003 Jan; 348(3):256-7; author reply 256-7. PubMed ID: 12529470
    [No Abstract]   [Full Text] [Related]  

  • 46. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Warfarin, aspirin, or both after myocardial infarction.
    Aronow WS
    N Engl J Med; 2003 Jan; 348(3):256-7; author reply 256-7. PubMed ID: 12530434
    [No Abstract]   [Full Text] [Related]  

  • 48. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
    Second Chinese Cardiac Study (CCS-2) Collaborative Group
    J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical practice. Aspirin for primary prevention of coronary events.
    Lauer MS
    N Engl J Med; 2002 May; 346(19):1468-74. PubMed ID: 12000818
    [No Abstract]   [Full Text] [Related]  

  • 50. Aspirin for first-line heart attack prevention. These is still no consensus; the benefits must be weighed against the risks.
    Duke Med Health News; 2014 Nov; 20(11):5-6. PubMed ID: 25481928
    [No Abstract]   [Full Text] [Related]  

  • 51. [Thrombolytic therapy of ischemic heart disease].
    Ishikawa K
    Nihon Naika Gakkai Zasshi; 1997 Sep; 86(9):1621-4. PubMed ID: 9410971
    [No Abstract]   [Full Text] [Related]  

  • 52. Effective platelet inhibition by aspirin and clopidogrel: where are we now?
    Tousoulis D; Briasoulis A; Dhamrait SS; Antoniades C; Stefanadis C
    Heart; 2009 May; 95(10):850-8. PubMed ID: 19401288
    [No Abstract]   [Full Text] [Related]  

  • 53. Aspirin for the primary prevention of cardiovascular events.
    Ferrini R; Clark B
    Am Fam Physician; 2002 Nov; 66(9):1737-8. PubMed ID: 12449273
    [No Abstract]   [Full Text] [Related]  

  • 54. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
    Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
    J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aspirin for everyone over 50? The buck stops in the consulting room.
    Kumar A
    BMJ; 2005 Jul; 331(7509):161; author reply 161. PubMed ID: 16020868
    [No Abstract]   [Full Text] [Related]  

  • 56. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
    Toth PP
    Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aspirin or warfarin: what's best after a heart attack? Risk of bleeding counters warfarin's edge in efficacy.
    Ornato JP
    Health News; 2002 Nov; 8(11):3. PubMed ID: 12523247
    [No Abstract]   [Full Text] [Related]  

  • 58. Aspirin for primary prevention of myocardial infarction: what is the evidence?
    Kappagoda T; Amsterdam E
    J Cardiopulm Rehabil Prev; 2012; 32(1):1-8. PubMed ID: 21946421
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiplatelet therapy and the prevention of thrombosis.
    Rodgers A; MacMahon S
    Aust N Z J Med; 1996 Apr; 26(2):210-5. PubMed ID: 8744620
    [No Abstract]   [Full Text] [Related]  

  • 60. [Non-cardiac surgery in patients with previous percutaneous coronary intervention according to the 2014 European guidelines].
    Rollini F; Franchi F; Angiolillo DJ
    G Ital Cardiol (Rome); 2015 May; 16(5):277-80. PubMed ID: 25994462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.